Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response.
Aug 2009 - Cancer Immunol. Immunother.; 58(10):1432-0851 [PMID:19225777]
[Delluc S] [Hachem P] [Rusakiewicz S] [Gaston A] [Marchiol-Fournigault C] [Tourneur L] [Babchia N] [Fradelizi D] [Regnault A] [Sang KH] [Chiocchia G] [Buzyn A]